Results

Total Results: 1,027 records

Showing results for "drug".

421. U.S. Preventive Services Task Force Recommends Statin Use for Primary Prevention of Cardiovascular Disease in High-Risk Adults (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/statins-news-bulletin.pdf
     November 13, 2016 - U.S. Preventive Services Task Force Recommends Statin Use for Primary Prevention of Cardiovascular Disease in High-Risk Adults ` USPSTF Bulletin An independent, volunteer panel of national experts in prevention and evidence-based medicine U.S. Preventive Services Task Force Recommends Statin Use for Prima…

422. Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/gYdxwvAQZ73SApY2Hosz_d
     October 11, 2019 - Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection drug … In the United States, new cases of HBV among adults are largely transmitted through injection drug use … Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection drug … -20 In the United States, new cases of HBV among adults are largely trans- mitted through injection drug

423. Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/KdQef_VDT2kmHDX4ddNWmR
     August 01, 2022 - Three types of IGRA are currently approved by the US Food and Drug Administration: T-SPOT.TB (Oxford … medication shown to prevent progression to active tu- berculosis; however, concerns about hepatotoxicity and drug … 1.08]); post hoc analyses showed a smaller number of cases of hepatotoxicity attributable to the study drug … increasing risk of progression to active disease (such as diabetes, lupus, cancer, alcoholism, and drug … Flu-like and other systemic drug reactions among persons receiving weekly rifapentine plus isoniazid

424. Draft Research Plan: Breastfeeding: Primary Care Behavioral Counseling Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/breastfeeding-interventions
     March 10, 2022 - individuals or infants (e.g., persons in institutions, infants with prenatal disease, infants born to drug-using

425. Evidence Summary: Anxiety in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-anxiety-children-adolescents
     October 11, 2022 - screening; diagnostic test accuracy studies; RCTs of cognitive behavioral therapy (CBT) or US Food and Drug … Eligible pharmacotherapy interventions included agents approved by the US Food and Drug Administration … Third, the review was limited to CBT and drugs approved for pediatric use by the US Food and Drug Administration … Scale; CBT, cognitive behavioral therapy; CGAS, Children’s Global Assessment Scale; FDA, US Food and Drug

426. Draft Research Plan: Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/tobacco-smoking-cessation-in-adults-including-pregnant-women-interventions
     March 15, 2018 - Food and Drug Administration as first-line tobacco cessation agents (e.g., clonidine, nortriptyline,

427. ahrq12a_Summary_HBP.qxd (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/BXkaHRFGjwUCoyANeMSuTz
     January 01, 2010 - Adverse Effects of Treatment of Hypertension Serious or life-threatening adverse drug reactions have … Additionally, treatment of adult hypertensive patients with drug therapy and possibly nonpharmacological … Clinical effectiveness of non-drug treatment for hypertension: a meta-analysis.

428. Draft Recommendation: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/lipid-disorders-children-adolescents-screening
     January 24, 2023 - Food and Drug Administration for use in children age 8 years or older and are the first-line pharmacotherapy … changes between the intervention and control groups. 1 Multifactorial Dyslipidemia No trials of drug

429. Final Research Plan: Chlamydia and Gonorrhea: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/chlamydia-and-gonorrhea-screening
     May 02, 2019 - Food and Drug Administration Outcomes KQ 1: Complications of infection (such as pelvic inflammatory

430. Final Research Plan: Cervical Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cervical-cancer-screening-adults-adolescents
     March 17, 2022 - Food and Drug Administration include: the Hybrid Capture 2 High-Risk HPV DNA Test (Qiagen, Hilden, Germany

431. Archived: Carotid Artery Stenosis: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/carotid-artery-stenosis-screening-1996
     January 01, 1996 - of atherosclerosis and reduced total cardiovascular events compared to placebo. 52A Lipid-lowering drug

432. Screening for Dementia - Recommendations and Rationale (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/T-DyWdyD67ktDMJGDp3jpm
     June 01, 2003 - There is fair to good evidence that several drug therapies have a beneficial effect on cognitive function … There is insufficient evidence to determine whether the benefits observed in drug trials are generalizable

433. Archived: Dementia in Older Adults: Screening, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/dementia-older-adults-screening-2003
     June 03, 2003 - There is fair to good evidence that several drug therapies have a beneficial effect on cognitive function … There is insufficient evidence to determine whether the benefits observed in drug trials are generalizable

434. U.S. Preventive Services Task Force Issues Final Recommendation on Screening for Syphilis Infection (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/syphilis-nonpregnant-adults-adolescents-screening-final-rec-bulletin.pdf
     September 27, 2022 - U.S. Preventive Services Task Force Issues Final Recommendation on Screening for Syphilis Infection http://www.uspreventiveservicestaskforce.org 1 U.S. Preventive Services Task Force Issues Final Recommendation on Screening for Syphilis Infection Task Force recommends screening people at increased risk fo…

435. Screening for Syphilis: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/TzddJozNQQZYmTohr64wMz
     June 07, 2016 - services and the use of screening tests that are currently available and cleared by the US Food and Drug … 73.6%- 75.8%), patients with no risk factors for syphilis (71.5%; 95% CI, 70.4%-72.5%), or intravenous drug … 66.3%-73.3%) and slightly lower for MSM (69%; 95% CI, 66.9%- 71.0%) and MSM who were also intravenous drug … users, 69.9% MSM and intravenous drug users, 68.0% Binnicker et al,28 2012 1000 MFI followed by RPR … US Food and Drug Administration. http://www .accessdata.fda.gov/cdrh_docs/reviews/k102400 .pdf.

436. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: A Reaffirmation Evidence Update for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/58hBPcVeu-tdsW8a2NE7jD
     January 01, 2019 - Regional care model enables rapid response to adverse drug events. J Perinatol. 2010;30(4):300. … Regional care model enables rapid response to adverse drug events. J Perinatol. 2010;30(4):300.

437. C97Uqjxbuhjnuondkvchzu (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/c97uqjXbUHjNuoNDkvChZu
     August 01, 2013 - The USPSTF has made recommendations on screening for illicit drug use and counseling and interventions … Monitoring the Future: National Survey Results on Drug Use, 1975–2011. … Drug Alcohol Depend. 2010;110:108-16. [PMID: 20236774] 30. Perrine MW, Peck RC, Fell JC.

438. Draft Recommendation: Syphilis Infection During Pregnancy: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/syphilis-infection-pregnant-persons
     November 19, 2024 - Food and Drug Administration. 10 Having the ability to get rapid, on-site results could potentially … have a history of HIV, incarceration, or multiple sexual partners; engage in sex in combination with drug … Food and Drug Administration.

439. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: A Reaffirmation Evidence Update for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/Home/GetFile/1/16935/GON-final-evidence-review/pdf
     January 01, 2019 - Regional care model enables rapid response to adverse drug events. J Perinatol. 2010;30(4):300. … Regional care model enables rapid response to adverse drug events. J Perinatol. 2010;30(4):300.

440. Final Research Plan: Glaucoma: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/glaucoma-october-2022
     August 13, 2021 - Food and Drug Administration (FDA)–approved medical treatments (latanoprostene bunod and netarsudil)